Olson James E, Martinho Eduardo
Department of Emergency Medicine, Wright State University School of Medicine, Cox Institute, Kettering, Ohio 45429, USA.
J Neurochem. 2006 Mar;96(5):1375-89. doi: 10.1111/j.1471-4159.2006.03652.x.
Taurine, an important mediator of cellular volume regulation in the central nervous system, is accumulated into neurons and glia by means of a highly specific sodium-dependent membrane transporter. During hyperosmotic cell shrinkage, net cellular taurine content increases as taurine transporter activity is enhanced via elevated gene expression of the transporter protein. In hypo-osmotic conditions, taurine is rapidly lost from cells by means of taurine-conducting membrane channels. We reasoned that changes in taurine transporter activity also might accompany cell swelling to minimize re-accumulation of taurine from the extracellular space. Thus, we determined the kinetic and pharmacological characteristics of neuronal taurine transport and the response to osmotic swelling. Accumulation of radioactive taurine is strongly temperature dependent and occurs via saturable and non-saturable pathways. At concentrations of taurine expected in extracellular fluid in vivo, 98% of taurine accumulation would occur via the saturable pathway. This pathway obeys Michaelis-Menten kinetics with a Km of 30.0 +/- 8.8 microm (mean +/- SE) and Jmax of 2.1 +/- 0.2 nmol/mg protein min. The saturable pathway is dependent on extracellular sodium with an effective binding constant of 80.0 +/- 3.1 mm and a Hill coefficient of 2.1 +/- 0.1. This pathway is inhibited by structural analogues of taurine and by the anion channel inhibitors, 4,4'-diisothiocyanostilbene-2, 2'-disulfonic acid (DIDS) and 5-nitro-2-(3 phenylpropylamino) benzoic acid (NPPB). NPPB, but not DIDS, also reduces the ATP content of the cell cultures. Osmotic swelling at constant extracellular sodium concentration reduces the Jmax of the saturable transport pathway by approximately 48%, increases Kdiff for the non-saturable pathway by 77%, but has no effect on cellular ATP content. These changes in taurine transport occurring in swollen neurons in vivo would contribute to net reduction of taurine content and resulting volume regulation.
牛磺酸是中枢神经系统中细胞容积调节的重要介质,它通过一种高度特异性的钠依赖性膜转运体累积到神经元和神经胶质细胞中。在高渗性细胞皱缩过程中,随着转运体蛋白基因表达升高,牛磺酸转运体活性增强,细胞内牛磺酸净含量增加。在低渗条件下,牛磺酸通过牛磺酸传导性膜通道迅速从细胞中丢失。我们推测,牛磺酸转运体活性的变化也可能伴随细胞肿胀,以尽量减少牛磺酸从细胞外空间的重新累积。因此,我们确定了神经元牛磺酸转运的动力学和药理学特征以及对渗透性肿胀的反应。放射性牛磺酸的累积强烈依赖温度,且通过可饱和和不可饱和途径发生。在体内细胞外液预期的牛磺酸浓度下,98%的牛磺酸累积将通过可饱和途径发生。该途径遵循米氏动力学,Km为30.0±8.8微摩尔(平均值±标准误),Jmax为2.1±0.2纳摩尔/毫克蛋白·分钟。可饱和途径依赖细胞外钠,有效结合常数为80.0±3.1毫摩尔,希尔系数为2.1±0.1。该途径受到牛磺酸结构类似物以及阴离子通道抑制剂4,4'-二异硫氰酸芪-2,2'-二磺酸(DIDS)和5-硝基-2-(3-苯丙基氨基)苯甲酸(NPPB)的抑制。NPPB而非DIDS也会降低细胞培养物中的ATP含量。在细胞外钠浓度恒定的情况下进行渗透性肿胀,可使可饱和转运途径的Jmax降低约48%,使不可饱和途径的Kdiff增加77%,但对细胞ATP含量无影响。体内肿胀神经元中发生的这些牛磺酸转运变化将有助于牛磺酸含量的净减少以及由此产生的容积调节。